94320 ⎘
Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups - condensed with carbocyclic rings or ring systems; Ortho- or peri-condensed ring systems; Ring systems of three rings; Aza-phenanthrenes Phenanthridines
COMPOUNDS FOR TREATING MICROBIAL INFECTIONS, METHODS OF MAKING AND USES THEREOF
#2ANTI-SARS-COV-2 DRUG
#3NUCLEIC ACID CROSSLINKING REAGENTS AND USES THEREOF
#4ANTI-SARS-COV-2 DRUG
#5MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#6NUCLEIC ACID MODIFYING REAGENTS AND USES THEREOF
#7INHIBITORS OF KIDNEY-TYPE GLUTAMINASE, GLS-1
#8Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis
#9Inhibitors of kidney-type glutaminase, GLS-1
#10Heterocyclic compound and organic light emitting device comprising same
#11Compounds having valerolactam structures
#12Theranostic nucleic acid binding fluorescent nanoprobes and uses thereof
#13HIV REPLICATION INHIBITOR
#14Nitrogen-containing polycyclic compound and organic light emitting element using same
#15Nucleic acid modifying agents and uses thereof
#16Corrosion Inhibition
#17Inhibitors of kidney-type glutaminase, GLS-1
#18Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis
#19Nitrogen-containing polycyclic compound and organic light emitting element using same
#20Heterocyclic compound and organic light emitting device using same
#21Polycyclic compound and organic electronic device comprising the same
#22Use of small molecule inhibitors targeting the interaction between RAC GTPase and p67
#23Phenanthridine derivatives, preparation methods and uses thereof
#24RADICAL ORBITAL SWITCHING
#25Estrogen receptor ligands and methods of use thereof
#26HIV REPLICATION INHIBITOR
#27Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
#28Extracting agent for separating lithium isotopes and use thereof
#29Nucleic acid binding dyes with improved safety
#30Supercritical fluid extraction of bis-benzyl isoquinolines
#31Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
#32Method of testing a disinfectant or antibiotic using phenanthridium derivatives
#33Estrogen receptor ligands and methods of use thereof
#34Polycyclic compound and organic electronic device comprising the same
#35Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#36Compounds and compositions as TLR activity modulators
#37Dihydroethidine analogues and uses thereof
#38THERAPEUTIC AGENT FOR HEPATITIS C
#39Method of microbial profiling of a sample using phenanthridium derivatives
#40Nuclear receptor binding agents
#41Benzo [C] phenanthridines as antimicrobial agents
#42Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors
#43Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
#44INHIBITORS OF HISTONE DEACETYLASE
#45Anthracene derivatives and organic electronic device using same
#46Anthracene derivative and an organic electronic device using the same
#47Compounds and compositions as TLR activity modulators
#48Estrogen receptor ligands and methods of use thereof
#49Novel Phenantridine Analogues and Uses Thereof
#50QUINOLINONE DERIVATIVES
#51Guanidinyl-substituted hydroxy-6-phenylphenanthridines
#52Use of phenanthridium derivatives for distinguishing between live and dead cells
#53Phenanthridine derivatives as bradykinin antagonists
#54Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
#55Inhibitors of Checkpoint Kinases
#56Method for producing benzazepinone
#573-hydroxy-6-phenylphenanthridines as PDE4 inhibitors
#58SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS
#59Nuclear receptor binding agents
#602-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
#61Antipruritics
#62Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#63Methods and Compositions for Selectin Inhibition
#64Amido-Substituted 6-Phenylphenanthridines
#65Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#66Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors
#67Nuclear receptor binding agents
#68Novel Difluoroethoxy-Substituted Hydroxy-6-Phenylphenanthridines and Their Use as Pde4 Inhibitors
#69Novel isoamido-substituted hydroxy-6-phenylphenanthridines
#70Novel heterocycle-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
#71Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors
#72Guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (PDE) 4 inhibitors
#73Serm reduction of lipid profiles
#7417-Acetamido-4-azasteroid derivatives as androgen receptor modulators
#75Novel 6-phenylphenantridines
#76Novel 6-phenlyphenanthridines
#77Liquid phase process for the synthesis of annulated pyridines over molecular sieve catalysts
#78Novel phenanthridines
#79Phenanthridine carbonyl phenols
#80Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines
#81Phenantridine analogues and uses thereof
#823-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
#832-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
#84Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#85Metabotropic glutamate receptor antagonists
#86Phenanthridinones as parp inhibitors
#87Antipruritics